Date: November 4-6th 2021 Venue: Javits Convention Center, Hall 3A, New York City, NY  Industry professionals in the legalized cannabis and hemp industry are invited to attend The Cannabis World Congress & Business Exposition (CWCBExpo), a business-to-business trade show and conference at the Javits Convention Center, Hall 3A, November 4-6, 2021. The event will be held in person and the convention center requires masks and proof of vaccination. More information can be found under the health and safety section of the venue’s website. The exposition is a three-day event where professionals will be able to participate in a wealth of curated and hosted content, including Inside the Industry: Thought Leadership Series. Geoff Whaling and Matthew Anderson will led this series in a “Talk Show” format, accompanied by influential and informed industry minds, with a different focus on each of the three days of the conference: Day 1: Where We Are Today; Day 2: Challenges and Solutions; Day 3: Where We Are Going. Notable speakers during these three days include, but are not limited to, Christopher “CJ” Wallace, Willie Mack, Faye Coleman, Calvin Frye, Hillary Peckham, Mike Hennesy and more. Conference program emcees for the event feature Keiko Beatie and Kymberly “KymB” Byrnes. Those in attendance at the CWCBExpo are also invited to a unique networking opportunity on November 4, from 5 pm to 7 pm EST. The “Back-to-Business Celebration” will be a chance for industry professionals to continue networking, discussing the trade, or simply unwinding before tackling the remaining two days of the conference. To purchase admittance to the celebration, attendees must be registered for the CWCBExpo. More information on registration can be found at https://cwcbexpo.com/registration_ny/. The CWCBExpo will be a great way to enjoy Cannabis Week (November 1-7), where the entire cannabis industry comes together for a week of learning, sharing, and connecting. For events and discounts during Cannabis Week, visit https://cwcbexpo.com/cannabis-week/ and check out the Cannabis Week Guide (now available and updated regularly). For more information about CWCBExpo, please visit https://cwcbexpo.com/.

The world’s largest and most powerful tech companies –Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) – are targeting an opportunity in health care that’s just too big to ignore – diabetes. Almost a third of the entire U.S. population – more than 100 million people in this country alone – are living with diabetes or are at high risk for the disease. Diabetes makes it difficult for the body to process sugar (glucose) and can lead to serious health issues and death. With $1 of every $4 of health care costs in the U.S. now spent on caring for people with diabetes, these tech giants are looking to snag a share of the multi-trillion-dollar global diabetes markets through innovation. Managing the disease relies way too much on guesswork and variables – random finger pricks to test blood sugar before trying to accurately adjust insulin dosage is far from perfect science. Plus, a multiplicity of lifestyle choices, like food and exercise, can severely impact people with the disease. Technology is key to helping people with diabetes better manage their disease, and the tech giants are all exploring how they can bring new services and tools to market.

• Alphabet, through its Verily subsidiary, teamed with DexCom Inc. (NASDAQ: DXCM) to bring continuous monitoring hardware to market. DexCom users insert a sensor under the skin and, after the sensor is inserted, a transmitter is snapped into place allowing users to check their readings via a smartphone or watch.
• Amazon makes it easier for people to access their readings via the Alexa voice assistant and promotes blood sugar monitoring devices on its marketplace.
• Apple is working closely with other medical device makers like Dexcom to build integrations with consumer devices like Apple Watch and iPhone.

Tech continues to provide creative solutions to better manage chronic diseases like diabetes. Nemaura Medical Inc. (NASDAQ: NMRD) has developed sugarBEAT(R) – a wearable, non-invasive and flexible continuous glucose monitor patch designed to help people with diabetes and prediabetes manage their glucose levels. sugarBEAT(R) consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with a smartphone app displaying glucose readings at five-minute intervals for periods of up to 24 hours. Users don’t have to draw blood samples or prick their fingers multiples times each day and can wear the patch on whatever days they choose. Other continuous glucose monitor devices on the market must be implanted under the skin. sugarBEAT(R) is the world’s first wearable and disposable monitor which offers the potential to radically change the way people manage their chronic disease conditions. Already cleared in the EU and FDA Pre Market Application (“PMA”) submitted, Nemaura’s patented skin surface blood monitoring technology has allowed the company to create additional products, which are in the pipeline. More information on its technology can be found at www.NemauraMedical.com. Thank goodness, technology is delivering previously unimagined solutions to human frailties and the management of chronic diseases. However, for the record it’s not altruism that’s driving these tech companies, there’s a business opportunity here that’s just too damn big to ignore. For more information, visit the company’s websites at www.NemauraMedical.com or www.MiBoKo.com. NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

• Playgon Games is a SaaS technology company focused on licensing its online gaming technology to gaming operators around the world
• The company has recently revealed that it saw player betting turnover rise to $24.2 million as of the first half of October, a 1500% increase relative to September’s $1.6 million
• The pandemic has hastened a switch away from physical casinos and towards online gaming; the online gaming market is now expected to grow to an annual value of $127.3 billion by 2027
• Playgon Games’ business model effectively allows investors to capitalize on overall gaming sector growth while simultaneously forgoing the sector’s elevated player acquisition costs

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), a propriety SaaS technology company delivering mobile live dealer technology to online gaming operators globally, has recently revealed that it has surpassed $24.2 million in player betting turnover in the first half of October 2021, up from a mere $1.6 million for the entire month of September (https://ibn.fm/tFsRa). Darcy Krogh, CEO of Playgon Games, commented regarding the results, “Daily player betting turnover is approximately $1.6 million per day, up from about $53,500 per day for the month of September. We are extremely excited about our month over month growth.” He continued, “We knew our proprietary technology was innovative, however the reception we have received from our partners and clients has been unparalleled. This is noticeable from the player wagering activity, which has increased to 305,000 bets for the half month of October compared to 132,000 bets for the entire month of September. We are witnessing at least 100% growth across all of our key indicators.” Playgon Game’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. The pandemic, consumer behaviour, technology, and regulation has hastened an already existing shift away from location-based casinos to online gaming; a recent study has forecast the global online gambling market to reach US$ 127.3 billion by 2027, representing a CAGR of 11.5 percent from 2020 to 2027 (https://ibn.fm/Ryfqv). The shift has primarily been driven by younger, tech-savvy consumer demographics, which has led to the adoption of digital gaming globally. To meet this demand, Playgon has launched a studio with ten gaming tables from which its live dealer streaming video originates. The company’s platform is now live with multiple online casino operators through direct integrations and four aggregator client integrations in South Africa and Europe, with further commitments from other parties still to come. Playgon has also recently revealed plans to expand their current studio to 25 tables in the near term and is working to establish a U.S. and LATAM strategy. In the future, the company will continue to expand licensing of its live dealer games to iGaming operators worldwide under a SaaS license agreement (https://ibn.fm/kH98f). (https://ibn.fm/G6LSC). Thus, and in its role as a B2B software supplier, Playgon Games is able to avoid incurring the elevated play acquisition costs faced by both physical and online gaming entities while simultaneously capitalizing on the growth of the growing online gambling market. As the saying goes in gambling, “the house always wins.” In Playgon Games’ case, they are the house, and the more visitors, the better. For more information, visit the company’s website at www.Playgon.com. NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF

• U.S.-based FingerMotion has been pursuing opportunities to provide text and multimedia message services in China, whose population is expected to exceed 1.4 billion people this year
• FingerMotion is expanding into a third channel of operations with the development of its trademarked big data platform Sapientus, and expects revenues from the tech platform to eventually exceed its SMS and MMS message services
• The company recently reported its Q2 financials, noting a 25 percent YOY quarterly growth in revenues attributed to SMS and MMS services, and an overall quarterly revenue growth to $5.39 million
• China is encouraging development of its insurance industry services, providing increased opportunities for leading global insurers such as Pacific Life
• Pacific Life Reinsurance finalized a contract with FingerMotion for Sapientus’ services earlier this year, strengthening FingerMotion’s position in supporting the insurtech industry

Communications and big data technology platform builder FingerMotion (OTCQX: FNGR) is welcoming signs of growth in its newly released Q2 report. The China-focused enterprise reported quarterly revenue of $5.39 million, which included a 25 percent year-over-year quarterly growth in its short and multimedia messaging (SMS and MMS) business revenue of $0.73 million. “Growth continues unabated with the SMS texting due to our optimized prepayments of bulk inventory purchases. Contributing to the growth and margin expansion was from the subscription plan and the mobile phone sales,” CEO Martin Shen stated in a news release about the financial filing (https://ibn.fm/cU7KK). “These optimized purchase programs and hardware sales and service improved gross profit from 7% to 13%. The Company is seeing strong demand in SMS from our corporate clientele.” Despite the positive news regarding texting and multimedia services, FingerMotion remains committed to improving its bottom line through the development of its trademarked Sapientus big data platform. The company noted a sharp increase in general and administrative expenses tied to research and development as the company continues to build up SMS, MMS and big data services simultaneously. “We are pleased at the strength of our balance sheet which hit a milestone of over $5.0 million in shareholders’ equity. This quarter was more of a transition to greater profitability as more of our initiatives started contributing to gross margin,” Shen stated. “This is the third consecutive quarter of Big Data revenues and we expect it to continue and eventually outpace our existing revenue streams.” During Q1, FingerMotion secured a landmark agreement with Pacific Life Re-insurance to provide Sapientus’ big data prowess as a tool for Pacific Life’s efforts to build its insurance offerings among China’s consumers. China’s population is expected to exceed 1.4 billion people this year, creating the potential of a world-leading base for economic activity. And the country’s leadership has been encouraging further development of the insurance industry, as noted in the China Banking and Insurance Regulatory Commission’s recent statement urging insurers to accelerate their offerings for gig-economy delivery workers, elderly people and children with congenital diseases and medical conditions (https://ibn.fm/nhWPu). But the country’s insurance risk and credit risk evaluation infrastructure is still underdeveloped, which poses a challenge for companies like Pacific Life — one of the world’s top five Insurance companies with $1.1 trillion in life insurance policies and $171 billion in assets (https://ibn.fm/6jhnI). Sapientus delivers predictive algorithms that help clients such as Pacific Life Reinsurance gain insights into consumer activity and risk potential. “This trend will continue and revenue should ramp as the insurtech business starts to develop,” Shen stated. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Lexaria’s THC absorption animal study yielded promising results on the patented DehydraTECH(TM) technology
• It showed that the technology required a shorter time to deliver the same THC levels than concentration-matched controls
• Lexaria believes that through DehydraTECH, it is meeting the needs of medical THC users with its rapid delivery, increased overall THC delivery and high brain tissue delivery

Lexaria Bioscience’s (NASDAQ: LEXX) just-concluded oral tetrahydrocannabinol (“THC”) absorption animal study, THC-A21-1, yielded promising results on the effectiveness of the company’s patented DehydraTECH(TM) drug delivery technology. The study, performed by a leading, independent laboratory, involved 20 male Sprague Dawley rats split into two groups of ten each. It followed the administration of the THC with brain tissues collected at 8 and 24 hours (https://ibn.fm/7S0D0). The study showed that DehydraTECH-THC delivered via oral ingestion required only 15 minutes to dispense THC levels proportional to those achieved at 45 minutes with concentration-matched controls. It also showed that DehydraTECH-THC delivered considerably more THC into the bloodstream compared to standard medium-chain triglyceride (“MCT” or “coconut oil”)- based control formulation, starting from the 2-minute mark onwards. It would then drop rapidly to the same level as the MCT control after 6 hours. While making the announcement, Chris Bunka, Lexaria’s Chief Executive Officer (“CEO”), noted, “THC users today include… medicinal and pharmaceutical users, all of whom need technology that doesn’t rely on harmful delivery methods such as smoking, but still provides rapid onset and high bioavailability which common oral formats do not offer.” Mr. Bunka acknowledged that with DehydraTECH, Lexaria offers a solution that considers medical THC users’ needs. He noted that the findings from this study are proof of the technology’s rapid delivery, increased overall THC delivery, and high brain tissue delivery, all of which are consistent with the needs and wants of medical THC customers. According to Harvard Medical School, medical cannabis use today is largely for pain control. Patients dealing with multiple sclerosis or nerve disorders have cited responding to cannabis treatment a lot better compared to opiates. This alternative has also proven to be more effective without the accompanying addictive or sedating effects linked to opiates. With DehydraTECH, Lexaria is proving that cannabis is not only integral to healthcare going forward but that it can also be administered effectively while still yielding better results for patients. DehydraTECH processing consistently proves its ability to deliver drugs more effectively into the bloodstream and the brain tissue. The THC-A21-1 study is a testament to that and an indication of the tremendous potential that the technology has, not just with THC delivery but also with nicotine, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), phosphodiesterase inhibitors and anti-viral drugs, among others. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

Date: November 2 – 4, 2021 Live Streaming Traders, investors, shareholders, and businesses are invited to attend the Interactive MoneyShow Virtual Expo on November 2-4, 2021. MoneyShow has been organizing conferences and seminars for over 40 years with a 100,000+ community of investors, financial heads, and businesses looking to gain knowledge and guidance about the latest investment tools, financial trends and opportunities from the stalwarts of the financial arena. The event presents a wonderful opportunity for traders and investors to interact with financial leaders and company experts via interactive message boards. The educational videos and articles serve as a source of a huge knowledge base for new traders, shareholders and investors seeking guidance on the management of investments and growth opportunities in the financial trading segment. The Interactive MoneyShow Expo showcases influential speakers who are eminent personas in their niche. Exhibitors can host live presentations and explain their product and service line in the Virtual Exhibit Hall while availing of great discounts and win numerous prizes in different events. This Virtual Exhibit Hall is a tremendous marketing forum where investors from different backgrounds understand your business and you get an opportunity to develop a long-term association with them. Attendees can participate for free to watch the interactive sessions and live presentations by distinguished financial leaders. These dignitaries will discuss who they are adapting their trading and investment plans as per the current market trends. They will also offer their insights and tips into the future course of action on stocks, bonds, and ETFs to options, futures, forex, and more. The interactive sessions offer an in-depth analysis of the current trends so that you can make better trading and investment decisions to enjoy better profits. Inflation will be an important agenda of discussion at the expo where attendees can get valuable guidance and key pointers for managing their investments in the current environment. Presentations will also include detailed explanations on how we can use non-dividend stocks and create our dividend-like cash flow by selling call options. The speaker sessions will be followed by real-life examples as to how to implement option-selling to create a dividend-like cash flow with non-dividend bearing stocks. To know more about the event, please visit https://ibn.fm/Q278k.

• In a recent interview, Jushi’s Executive VP of Business Development, Olivier Blechner, shared the company’s plans to increase the number of its cannabis stores progressively from the current 24 to 36
• Jushi is also expanding its production facilities in Pennsylvania, Virginia, and Massachusetts
• The company, which recently closed the purchase of Nature’s Remedy of Massachusetts, Inc. (“Nature’s Remedy”) and announced signing a definitive agreement to acquire an operating dispensary in Las Vegas, Nevada, is eying additional acquisitions
• Jushi participated in several conferences this month, including the Benzinga Cannabis Capital, MJBizCon and MJ Unpacked

As a company committed to setting the new standard for a sophisticated, modern cannabis experience, Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF) has made substantial strides in fulfilling this vision. In a recent interview with IBN’s Jonathan Keim, Olivier Blechner, Jushi’s Executive VP of Business Development, delineated key milestones and the company’s growth throughout its now three and a half years of existence. From its initial retail-focused beginnings, Jushi has made significant inroads in the cultivation and production of cannabis, adopting a vertically integrated model that it has implemented in various states, including some major markets – Pennsylvania, Virginia, and Massachusetts. It is now a multi-state cannabis operator focused on building assets in limited license medical markets and high-growth, large adult use markets that are limited at the state or jurisdictional level where it can create the greatest return on investments for its shareholders. Currently, Jushi holds permitted licenses to run 36 cannabis retail stores. Of these, the company operates 24 stores, with the expectation that it will operate five more before year-end and seven more next year. This company’s expansion plans follow a two-pronged investment and growth strategy that encompasses capital expenditure (“CapEx”), along with mergers and acquisitions (“M&A”). For the company to invest in a prospect, Blechner said, “it has to significantly expand and fortify our position in an existing market, or it has to be an additional market that is just as good if not better than what we have already.” This approach means that all potential investment projects compete internally for capital as the company only expects to channel funds into the best opportunities possible. Using this approach, Jushi has made high-return and low-risk investments through CapEx – it currently is in the process of expanding its facilities in a phased approach in Pennsylvania and Virginia and is growing Nature’s Remedy in Massachusetts. Similarly through M&A, the company recently announced signing a definitive agreement to acquire an operating dispensary in Las Vegas, Nevada (https://ibn.fm/JNSKm) and closing the previously announced acquisition of Nature’s Remedy (https://ibn.fm/aEnHz), as well as eyeing additional purchases in line with its M&A strategy, “The M&A market is still very interesting to us, and we see significant opportunities to expand our presence in states that we are operating in already, as well as selectively expand into new states.” Through M&A-induced and/or license application growth, Jushi expects to expand its BEYOND / HELLO(TM) store count in Illinois from 5 to 10. It also plans to add one more store in Massachusetts, bringing its total to three, the maximum limit of cannabis stores a company can own in the state. Further, Jushi intends to leverage organic growth to open the remaining three licensed stores for a total of 18 dispensaries open in Pennsylvania. As well as opening one dispensary this year in Virginia and California this year and the remaining four in Virginia and one in California next year. Individually and collectively, these markets provide Jushi’s asset base with the greatest growth potential. In Illinois, for example, many multi-state operators (“MSOs”) with whom Jushi is competing have already hit their limit of cannabis stores, yet Jushi can add five more. As for Pennsylvania, there are discussions the Commonwealth is looking to shift from medical cannabis use to recreational use, on the heels of a similar switch in Virginia. Jushi’s M&A strategy has greatly benefited from the company being publicly traded. This status has eased its ability to raise cash that it can use for current and future investments. For instance, Jushi closed on an approximate $122 million in gross proceeds (or $115 million net proceeds) from three equity financings since October 2020, which, according to Blechner, is being put to excellent use, with Nature’s Remedy as a prime M&A example and CapEx on the company’s facilities as the other example. Further, given the increased ability for employees to own stock in the organization they work for, a publicly traded company provides a great retention tool and a way to pool the team together. Mr. Blechner also discussed Jushi’s conference participation this month. These include:

• Benzinga Cannabis Capital Conference, New York: October 14-15
• MJBizCon, Las Vegas: October 19-21
• MJ Unpacked, Las Vegas: October 21-22

For more information, visit the company’s website at www.JushiCo.com.

• PlantX Life Inc. is a growing global presence as a one-stop shopping and educational hub building a sense of community for the world’s plant-based lifestyle pursuits
• The company announced Oct. 19 that its wholly owned subsidiary Bloomboxclub Limited, based in the United Kingdom, has launched a web domain and market outreach in Canada
• Bloombox Club’s United Kingdom operation has been responsible for delivering more than 100,000 plants to over 50,000 customers
• PlantX Life’s weekly podcast series, YouTube channel videos, informative blog and e-commerce portal accessible through Walmart’s and Amazon’s Marketplace provide product sales and tips on healthy living, home plant ownership and recipes accessible to beginners and more experienced consumers alike
• The company recently opened a store in British Columbia, Canada, has an affiliated operation in California and plans to launch a website in Israel next month

Digital plant community products and lifestyle hub PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is establishing an expanding line of category verticals designed to firmly root its status as a one-stop shopping and education dynamo, selling more than 5,000 products in line with its mission and anticipating eventual forays into cosmetics, clothing and other product brands. On Oct. 19 PlantX Life celebrated the announcement of another indoor plant vertical’s growth as wholly owned subsidary Bloomboxclub Limited (“Bloombox Club”) entered Canada as a direct-to-consumer indoor plant-selling business platform. Bloombox Club is an e-commerce platform for indoor plants based in the United Kingdom. With its expansion to Canada under the new domain https://bloomboxclub.ca/, the wellness community is gaining new options for access to high-quality indoor plants, plant-care packages, self-care packages, planting pots and accessories. In the United Kingdom and Germany, Bloombox Club has delivered more than 100,000 plants to over 50,000 customers, according to the announcement (https://ibn.fm/s9KjY). The company has also begun expanding its range with plants that can live outside as well as indoors, including tea plants, citrus trees and an olive tree (https://ibn.fm/jbY7z). Parent company PlantX similarly is establishing an international growth presence through its flagship storefront in Canada’s Squamish, British Columbia and additional physical stores it is establishing in the United States (California market) and the State of Israel (https://ibn.fm/Ool9P). PlantX applied to the Toronto Stock Exchange (“TSX”) earlier this month to uplist its common shares in an effort to increase its access to capital markets. “Uplisting our shares to the TSX will mark a valuable milestone that will highlight PlantX’s impact and potential as a global leader in the plant-based industry. This is a crucial step in our growth that will significantly increase our brand recognition and could lead to enhanced trading activity,” CEO Lorne Rapkin stated (https://ibn.fm/Tt8bD). PlantX’s wellness community ecosystem efforts involve eliminating barriers for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life, which means providing food-preparation tips, fitness and health insights, and education on home plant ownership through a podcast series, YouTube channel and blog outreach. “We are looking forward to showing our customers that plant-based food is not only delicious but also highly accessible and fun for all, whether they are vegan or otherwise,” Rapkin stated (https://ibn.fm/JHNjT). For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Red White & Bloom completed the build-out of its Apopka facility – phase one of a development strategy – and immediately commenced cultivation following the receipt of a cultivation license
• The initial licensed area is projected to generate annual revenue in excess of $10 million
• The Apopka facility will support phase two of the strategy, which entails the activation of thirty customized, self-contained growing pods
• Phase three will involve the activation of a 113,000 SF facility for cultivation located in Sanderson

Upon closing the acquisition of an operational 45,000 square-foot greenhouse situated on 4.7 acres of land in Apopka, Florida in early August (https://ibn.fm/l3Pye), the team at Red White & Bloom Florida LLC, a Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) subsidiary, embarked on the rapid development of the facility to ensure all compliance standards are achieved. The rapid development – build-out of Apopka – would constitute phase one of an aggressive three-phase development strategy for its Apopka and Sanderson facilities. In an October 12 press release, RWB announced that it had completed phase one of the strategy. In addition, having received regulatory approval to begin cultivation toward the end of September, RWB commenced operations on September 30 (https://ibn.fm/UcOrt). The initial licensed area in Apopka is capable of producing 85 g of flower per plant, translating to projected annual revenue in excess of $10 million. With a projected Q4 2021 harvest schedule in the facility, RWB has hired additional cultivation specialists specifically for the Florida project, fulfilling an earlier projection that the center would add tens of additional employment opportunities for the local community when fully operational. “We brought this site into production ahead of forecast and ahead of budget, and I’m very proud of our Florida team,” stated RWB CEO Brad Rogers. “Despite being relatively new players in the Florida market, I feel we have the most talented team of PhDs and horticulturalists, and an incredible grow infrastructure to bring the highest quality products, rich in terpenes and cannabinoid content, to some of the best retail locations in the state starting Q1 2022.” The Apopka facility will supply RWB’s phase two of the strategy, which entails activating thirty 16’ by 40’ customized, self-contained growing pods. First announced on April 6, the pods are part of the company’s plans to increase cultivation capacity by collectively providing about 19,000 square feet of operating space, with 14,400 square feet of canopy. They will also provide a unique opportunity for RWB to produce ultra-premium products for the Florida market (https://ibn.fm/hWmGK). With a targeted Q4 launch, the pods are expected to yield nearly 10,000 pounds of dried flower annually, representing a current market value of $30 million. The pods will be deployed at the Sanderson Property, which covers over 15 acres of land and houses a 113,000 square-foot facility for cultivation and processing. Notably, the activation of the latter facility constitutes the company’s third phase of the strategy. As a company committed to becoming the superior and most recognizable cannabis company in the United States, RWB’s ethos covers retail, brands, and cultivation. In Florida, where it has already commenced cultivation, the company earlier announced that it would brand its Florida medical dispensaries beginning in Q4 and is developing a consistent retail footprint and product line to align with the medical market in Florida. RWB also boasts premium THC and CBD brands, including Platinum Vape, HighTimes, and more (https://ibn.fm/BlYjh). For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• Infobird continues to provide the Chinese market with technological solutions that optimize customer service, engagement, and overall experience through SaaS products that leverage AI solutions
• Customer engagement and salesforce management products currently available through Infobird are designed to help create optimized experiences for the customer and the company using them
• Infobird has over a decade of experience providing customer engagement and SaaS for large enterprises in the finance industry
• The SaaS market grows each year by approximately 18%, and it is estimated that by the end of 2021, 99% of businesses will utilize at least one SaaS product

Infobird (NASDAQ: IFBD) continues to show its dedication and commitment to improving its offering by successfully expanding into the consumer and retail product providers market, as shown in the August service contract signed by the company and the subsidiary of a leading retail brand. This service contract allows Infobird to expand its software-as-a-service (SaaS) offering, providing innovative AI-powered customer engagement solutions in China. Infobird empowers clients with business-driven solutions that help increase revenue, reduce costs, and enhance customer service quality and satisfaction. The company has over ten years of experience providing customer engagement and SaaS for large enterprises in the finance industry. The company’s comprehensive customer engagement SaaS solutions portfolio is highly intelligent, customizable, provides proof of stability and security at scale, and includes a concurrence of over 10,000 agents. Customer engagement products provided by Infobird include:

• Cloud Call Center – helps with improving customer satisfaction, increasing value per customer, and enhances the customer service experience through intelligent call routing, human/robot collaboration service, more than one method of deployment, customer engagement hub, and so much more
• Intelligent Telemarketing – Enhances work efficiency and increases success rates; offers predictive dialing, human/robot collaboration, multi-channel and media coordination, intelligent outbound routing strategies, cloud-native technology, full-stack capability with controlled source coding, and more
• Intelligent Omni-Channel Customer Service – Elevates customer experience with omnichannel engagement, human/robot collaboration, multidimensional data insights, and more
• AI Voice/Text Chatbot – allows for most questions to be answered 24/7, increases efficiency by almost 200%, decreases labor costs by up to 80%, chatbot works alongside human co-workers, utilizes powerful technology for speech recognition and synthesis, including semantic understanding, and more

AI salesforce management includes:

• Intelligent Quality Inspection – Improves quality inspection rates and service levels through real-time and total smart coverage, over 100 times more efficient, increases accuracy, increases agent capability, lowers complaint rates, lowers labor costs, and more
• Intelligent Training – Ensures and continuously improves the performance level of agents, reduces the high turnover rates and costs experienced during training, empowers agents to improve performance continuously, includes a standard curriculum, and more

The SaaS market is currently growing by 18% each year, and it is estimated that by the end of this year, 99% of organizations will be using one or more SaaS solutions. SaaS offers users opportunities that provide high strategic value, replacing on-premises deployment of software solutions. Through SaaS technologies, like those offered by Infobird, small and large businesses have the opportunity to expand and become more efficient (https://ibn.fm/sNZRq). Within the Chinese market, Infobird is hoping to expand through contracts, like the one signed in August. Many companies are implementing more optimized solutions for customer engagement, enhancing the customer experience through technological means. Infobird is aware of the trends, goals, and requirements, which is why it has been investing steadily in the technological innovation of its services. For more information, visit the company’s website at www.Infobird.com/en/index. NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD